C-reactive protein and white blood cell count after prostate biopsy in patients under antibiotic coverage
      The aim of the present study is to evaluate plasma C-reactive protein (CRP) levels in patients, who underwent transrectal ultrasound-guided prostate biopsy (TRUSPB), using prophylactic 24 hours or 5 days of antibiotics regimen.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Urology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect